Voyager Therapeutics's total assets for Q3 2024 were $426.04M, a decrease of -2.33% from the previous quarter. VYGR total liabilities were $95.73M for the fiscal quarter, a -5.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.